Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,585.00    139.00 (3.13%)
Bid:
4,598.00
Ask:
4,600.00
Spread: 2.00 (0.043%)
Market Cap: £99.03b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Board and Committee Changes

6 Feb 2024 07:00

RNS Number : 0508C
British American Tobacco PLC
06 February 2024
 

?February 2024

British American Tobacco p.l.c. (the 'Company')

Board and Committee Changes

The Company announces that Sue Farr and Dimitri Panayotopoulos will step down from the Board with effect from the conclusion of the Company's AGM on 24 April 2024 having served as Non-Executive Directors for nine years.

As a result of these departures, the Company announces changes to the role of Senior Independent Director and to the composition of the Audit and Remuneration Committees.

With effect from the conclusion of the Company's AGM on 24 April 2024:

- Holly Keller Koeppel will be appointed as Senior Independent Director, succeeding Sue Farr. Holly has been a Non-Executive Director of the Company since July 2017 and she is currently Chair of the Audit Committee and a member of the Nominations Committee.

 

- Darrell Thomas will be appointed as Chair of the Audit Committee, succeeding Holly Keller Koeppel, who will remain a member of the Audit Committee.

 

- Kandy Anand will be appointed as Chair of the Remuneration Committee, succeeding Dimitri Panayotopoulos.

Commenting of the changes, Luc Jobin, said: "I would like to thank both Sue and Dimitri for their extensive contribution to the Board over their tenures. I would also like to thank Holly for chairing the Audit Committee since 2019. I look forward to welcoming Holly, Darrell and Kandy to their new roles."

From the conclusion of the 2024 AGM, the memberships of the Company's Audit and Remuneration Committees will be:

Audit Committee

Remuneration Committee

Chair: Darrell Thomas

Chair: Kandy Anand

Holly Keller Koeppel

Murray S. Kessler

Karen Guerra

Serpil Timuray

Véronique Laury

 

The above proposals are subject to re-election of each of the Directors at the 2024 AGM.

This announcement is made in accordance with LR 9.6.11.

Enquiries:

British American Tobacco Press Media Centre

+44 (0) 20 7845 2888 (24 hours) | @BATplc

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

Yetunde Ibe: +44 (0)20 7845 1095

John Harney: +44 (0)20 7845 1263

Jane Henderson: +44 (0)20 7845 1117

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGZMKNGDZM
Date   Source Headline
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:35 pmRNSTotal Voting Rights and Issue of Shares
1st Apr 20262:30 pmRNSDirector/PDMR Shareholding
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 202612:00 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20262:40 pmRNSDirector/PDMR Shareholding
25th Mar 20262:35 pmRNSDirector/PDMR Shareholding
25th Mar 20262:30 pmRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20264:10 pmRNSDirector/PDMR Shareholding
20th Mar 20264:05 pmRNSDirector/PDMR Shareholding
20th Mar 20264:00 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 202611:35 amRNSPublication of a Prospectus
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20264:00 pmRNSIssue of Shares
17th Mar 20267:05 amRNSTransaction in Own Shares
17th Mar 20267:05 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSBranch Register: Dividend Finalisation Information
17th Mar 20267:00 amRNSBranch Register: Dividend Finalisation Information
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSNotice of AGM
10th Mar 202612:30 pmRNSNotice of AGM
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 202612:30 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20261:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.